Global Nanobody Discovery Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029
1 Market Overview
- 1.1 Product Overview and Scope of Nanobody Discovery Service
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Nanobody Discovery Service by Type
- 1.3.1 Overview: Global Nanobody Discovery Service Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Nanobody Discovery Service Consumption Value Market Share by Type in 2022
- 1.3.3 Screening and Development Services
- 1.3.4 Engineering and Optimization Services
- 1.3.5 Production and Expression Services
- 1.3.6 Other Services
- 1.4 Global Nanobody Discovery Service Market by Application
- 1.4.1 Overview: Global Nanobody Discovery Service Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Drug Discovery
- 1.4.3 Biological Engineering
- 1.4.4 Clinical Diagnosis
- 1.4.5 Immune Research
- 1.4.6 Others
- 1.5 Global Nanobody Discovery Service Market Size & Forecast
- 1.6 Global Nanobody Discovery Service Market Size and Forecast by Region
- 1.6.1 Global Nanobody Discovery Service Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Nanobody Discovery Service Market Size by Region, (2018-2029)
- 1.6.3 North America Nanobody Discovery Service Market Size and Prospect (2018-2029)
- 1.6.4 Europe Nanobody Discovery Service Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Nanobody Discovery Service Market Size and Prospect (2018-2029)
- 1.6.6 South America Nanobody Discovery Service Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Nanobody Discovery Service Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Creative Biolabs
- 2.1.1 Creative Biolabs Details
- 2.1.2 Creative Biolabs Major Business
- 2.1.3 Creative Biolabs Nanobody Discovery Service Product and Solutions
- 2.1.4 Creative Biolabs Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Creative Biolabs Recent Developments and Future Plans
- 2.2 Curia
- 2.2.1 Curia Details
- 2.2.2 Curia Major Business
- 2.2.3 Curia Nanobody Discovery Service Product and Solutions
- 2.2.4 Curia Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Curia Recent Developments and Future Plans
- 2.3 Sanofi
- 2.3.1 Sanofi Details
- 2.3.2 Sanofi Major Business
- 2.3.3 Sanofi Nanobody Discovery Service Product and Solutions
- 2.3.4 Sanofi Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Sanofi Recent Developments and Future Plans
- 2.4 NanoTag Biotechnologies
- 2.4.1 NanoTag Biotechnologies Details
- 2.4.2 NanoTag Biotechnologies Major Business
- 2.4.3 NanoTag Biotechnologies Nanobody Discovery Service Product and Solutions
- 2.4.4 NanoTag Biotechnologies Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 NanoTag Biotechnologies Recent Developments and Future Plans
- 2.5 Shanghai Medicilon Inc.
- 2.5.1 Shanghai Medicilon Inc. Details
- 2.5.2 Shanghai Medicilon Inc. Major Business
- 2.5.3 Shanghai Medicilon Inc. Nanobody Discovery Service Product and Solutions
- 2.5.4 Shanghai Medicilon Inc. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Shanghai Medicilon Inc. Recent Developments and Future Plans
- 2.6 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
- 2.6.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Details
- 2.6.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Major Business
- 2.6.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product and Solutions
- 2.6.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments and Future Plans
- 2.7 Yeasen Biotechnology(Shanghai)Co.,Ltd.
- 2.7.1 Yeasen Biotechnology(Shanghai)Co.,Ltd. Details
- 2.7.2 Yeasen Biotechnology(Shanghai)Co.,Ltd. Major Business
- 2.7.3 Yeasen Biotechnology(Shanghai)Co.,Ltd. Nanobody Discovery Service Product and Solutions
- 2.7.4 Yeasen Biotechnology(Shanghai)Co.,Ltd. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Yeasen Biotechnology(Shanghai)Co.,Ltd. Recent Developments and Future Plans
- 2.8 Fortis Life Sciences
- 2.8.1 Fortis Life Sciences Details
- 2.8.2 Fortis Life Sciences Major Business
- 2.8.3 Fortis Life Sciences Nanobody Discovery Service Product and Solutions
- 2.8.4 Fortis Life Sciences Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Fortis Life Sciences Recent Developments and Future Plans
- 2.9 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
- 2.9.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Details
- 2.9.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Major Business
- 2.9.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product and Solutions
- 2.9.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments and Future Plans
- 2.10 Biointron Biological Inc.
- 2.10.1 Biointron Biological Inc. Details
- 2.10.2 Biointron Biological Inc. Major Business
- 2.10.3 Biointron Biological Inc. Nanobody Discovery Service Product and Solutions
- 2.10.4 Biointron Biological Inc. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Biointron Biological Inc. Recent Developments and Future Plans
- 2.11 SAFE Pharmaceutical Technology Co., Ltd.
- 2.11.1 SAFE Pharmaceutical Technology Co., Ltd. Details
- 2.11.2 SAFE Pharmaceutical Technology Co., Ltd. Major Business
- 2.11.3 SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Product and Solutions
- 2.11.4 SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 SAFE Pharmaceutical Technology Co., Ltd. Recent Developments and Future Plans
- 2.12 Abterra Biosciences
- 2.12.1 Abterra Biosciences Details
- 2.12.2 Abterra Biosciences Major Business
- 2.12.3 Abterra Biosciences Nanobody Discovery Service Product and Solutions
- 2.12.4 Abterra Biosciences Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Abterra Biosciences Recent Developments and Future Plans
- 2.13 Chengdu Apak Biotechnology Co., Ltd.
- 2.13.1 Chengdu Apak Biotechnology Co., Ltd. Details
- 2.13.2 Chengdu Apak Biotechnology Co., Ltd. Major Business
- 2.13.3 Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Product and Solutions
- 2.13.4 Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 Chengdu Apak Biotechnology Co., Ltd. Recent Developments and Future Plans
- 2.14 ICarTab Biomedical Co., Ltd.
- 2.14.1 ICarTab Biomedical Co., Ltd. Details
- 2.14.2 ICarTab Biomedical Co., Ltd. Major Business
- 2.14.3 ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Product and Solutions
- 2.14.4 ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.14.5 ICarTab Biomedical Co., Ltd. Recent Developments and Future Plans
- 2.15 Wuhan Daian Biotech Ltd
- 2.15.1 Wuhan Daian Biotech Ltd Details
- 2.15.2 Wuhan Daian Biotech Ltd Major Business
- 2.15.3 Wuhan Daian Biotech Ltd Nanobody Discovery Service Product and Solutions
- 2.15.4 Wuhan Daian Biotech Ltd Nanobody Discovery Service Revenue, Gross Margin and Market Share (2018-2023)
- 2.15.5 Wuhan Daian Biotech Ltd Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Nanobody Discovery Service Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Nanobody Discovery Service by Company Revenue
- 3.2.2 Top 3 Nanobody Discovery Service Players Market Share in 2022
- 3.2.3 Top 6 Nanobody Discovery Service Players Market Share in 2022
- 3.3 Nanobody Discovery Service Market: Overall Company Footprint Analysis
- 3.3.1 Nanobody Discovery Service Market: Region Footprint
- 3.3.2 Nanobody Discovery Service Market: Company Product Type Footprint
- 3.3.3 Nanobody Discovery Service Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Nanobody Discovery Service Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Nanobody Discovery Service Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Nanobody Discovery Service Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Nanobody Discovery Service Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Nanobody Discovery Service Consumption Value by Type (2018-2029)
- 6.2 North America Nanobody Discovery Service Consumption Value by Application (2018-2029)
- 6.3 North America Nanobody Discovery Service Market Size by Country
- 6.3.1 North America Nanobody Discovery Service Consumption Value by Country (2018-2029)
- 6.3.2 United States Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 6.3.3 Canada Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Nanobody Discovery Service Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Nanobody Discovery Service Consumption Value by Type (2018-2029)
- 7.2 Europe Nanobody Discovery Service Consumption Value by Application (2018-2029)
- 7.3 Europe Nanobody Discovery Service Market Size by Country
- 7.3.1 Europe Nanobody Discovery Service Consumption Value by Country (2018-2029)
- 7.3.2 Germany Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 7.3.3 France Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 7.3.5 Russia Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 7.3.6 Italy Nanobody Discovery Service Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Nanobody Discovery Service Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Nanobody Discovery Service Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Nanobody Discovery Service Market Size by Region
- 8.3.1 Asia-Pacific Nanobody Discovery Service Consumption Value by Region (2018-2029)
- 8.3.2 China Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 8.3.3 Japan Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 8.3.5 India Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 8.3.7 Australia Nanobody Discovery Service Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Nanobody Discovery Service Consumption Value by Type (2018-2029)
- 9.2 South America Nanobody Discovery Service Consumption Value by Application (2018-2029)
- 9.3 South America Nanobody Discovery Service Market Size by Country
- 9.3.1 South America Nanobody Discovery Service Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Nanobody Discovery Service Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Nanobody Discovery Service Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Nanobody Discovery Service Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Nanobody Discovery Service Market Size by Country
- 10.3.1 Middle East & Africa Nanobody Discovery Service Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Nanobody Discovery Service Market Size and Forecast (2018-2029)
- 10.3.4 UAE Nanobody Discovery Service Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Nanobody Discovery Service Market Drivers
- 11.2 Nanobody Discovery Service Market Restraints
- 11.3 Nanobody Discovery Service Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Nanobody Discovery Service Industry Chain
- 12.2 Nanobody Discovery Service Upstream Analysis
- 12.3 Nanobody Discovery Service Midstream Analysis
- 12.4 Nanobody Discovery Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Nanobody Discovery Service market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Nanobody discovery service is a nanobody-based technology for screening and discovering nanobodies with high affinity and specificity. Nanobodies are natural single-chain antibodies that exist in the serum of camelids and sharks . Compared with traditional antibodies, nanobodies have the advantages of small molecular weight, good stability, and strong tissue penetration ability. Because they have no light chain structure, they can be flexibly combined with various antibody molecules. They are used in bispecific antibody drugs and cell therapy drugs. It has broad application prospects in the field of disease diagnosis and treatment, such as diagnosis and detection.
The Global Info Research report includes an overview of the development of the Nanobody Discovery Service industry chain, the market status of Drug Discovery (Screening and Development Services, Engineering and Optimization Services), Biological Engineering (Screening and Development Services, Engineering and Optimization Services), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nanobody Discovery Service.
Regionally, the report analyzes the Nanobody Discovery Service markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nanobody Discovery Service market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nanobody Discovery Service market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nanobody Discovery Service industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Screening and Development Services, Engineering and Optimization Services).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nanobody Discovery Service market.
Regional Analysis: The report involves examining the Nanobody Discovery Service market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nanobody Discovery Service market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nanobody Discovery Service:
Company Analysis: Report covers individual Nanobody Discovery Service players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nanobody Discovery Service This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Drug Discovery, Biological Engineering).
Technology Analysis: Report covers specific technologies relevant to Nanobody Discovery Service. It assesses the current state, advancements, and potential future developments in Nanobody Discovery Service areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nanobody Discovery Service market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nanobody Discovery Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Screening and Development Services
Engineering and Optimization Services
Production and Expression Services
Other Services
Market segment by Application
Drug Discovery
Biological Engineering
Clinical Diagnosis
Immune Research
Others
Market segment by players, this report covers
Creative Biolabs
Curia
Sanofi
NanoTag Biotechnologies
Shanghai Medicilon Inc.
Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
Yeasen Biotechnology(Shanghai)Co.,Ltd.
Fortis Life Sciences
Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
Biointron Biological Inc.
SAFE Pharmaceutical Technology Co., Ltd.
Abterra Biosciences
Chengdu Apak Biotechnology Co., Ltd.
ICarTab Biomedical Co., Ltd.
Wuhan Daian Biotech Ltd
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nanobody Discovery Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nanobody Discovery Service, with revenue, gross margin and global market share of Nanobody Discovery Service from 2018 to 2023.
Chapter 3, the Nanobody Discovery Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nanobody Discovery Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nanobody Discovery Service.
Chapter 13, to describe Nanobody Discovery Service research findings and conclusion.